20th Mar 2023

Genedrive® MT-RNR1 to commence roll out in Greater Manchester

genedrive plc (AIM:GDR), the point of care molecular diagnostics company, announces that the Ge...

9th Feb 2023

Antibiotic Induced Hearing Loss test receives preliminary recommendation by NICE

genedrive plc (AIM:GDR), the point of care molecular diagnostics company, announces that the UK...

21st Nov 2022

Audited Final Results

genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces its audited...